NHL Hockey Star Fernando Pisani and 24 Kids From Across Canada Raise dollor 20 000 for Ulcerative Colitis and Crohns Disease
Press releases distributed via CNW Group. VANCOUVER, Aug. 31 /CNW/ - Free Energy International Inc. ('Free Energy'
or the 'Company') has been contracted by one of North America's largest
independent oil and gas exploration and production companies to install one or
User comments, Ratings and Reviews
[Bookmark & read later
/ Comment this story ]
/ realated stories]
Article Taged as : hockey, star, fernando, pisani, kids, from, across, canada, raise, dollor, ulcerative, colitis, crohns, disease, http, rss.newswire.ca, newswire, rls_today_en.xml, hockey, star, fernando, pisani, kids, from, across, canada, raise, dollor, ulcerative, colitis, crohns, disease,
|
Article Statistics
Article Viewed 492 times.
Positive attitude 1 votes [0%]
Negetive attitude 1 votes [0%]
News Article Source & Groups
CNW Group | Today's news releases
Press releases distributed via CNW Group.
The Submitted XML Type text/xml and gathered so far 1 bytes of news and keep on growing.
Submit Server name is and Code Page (Not Defined/Un Known)
: : NHL Hockey Star Fernando Pisani and 24 Kids From Across Canada Raise dollor 20 000 for Ulcerative Colitis and Crohns Disease
Date Listed : Monday, August 31, 2009
Source : ,
|
Related Stories
- Stephen Tsang, Columbia University - Keynote Speaker at Ocular Disease Conference
Stephen Tsang, Associate Director, Edward S. Harkness Eye Institute, Columbia University/New York Presbyterian Hospital will give a Keynote Presentation on Transplantation of Reprogrammed Embryonic Stem Cells Improves Visual Function in ...- Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016
The global Huntington’s disease (HD) market was worth $243m in 2009. The market is expected to grow by 17.4% during the next seven years to reach $748m by 2016. Earlier, ...- Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016
The coronary artery disease (CAD) market is a highly competitive market and is expected to become more competitive until 2016. Three major patent expiries are expected during the forecast period, ...- Â Infectious Diseases Drugs Markets
According to the World Health Organization (WHO), six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and young adults. ...- Springmasters Canada Is A Leading Residential Property Maintenance Company
Springmasters Canada is a leading residential property maintenance company that deals in services like lawn care, driveway sealing, window washing, core aeration and dethatching. The company follows a transparent pricing ...- Asbestos Removal, Demolition, Mold Remediation, Lead Abatement, PCB's: Toronto Ontario Canada's leading Environmental Remediation companies since 1989
(1888PressRelease) Restoration Environmental REC Environmental Remediation has been successfully been removing Asbestos, Mold, Lead, all Hazardous Materials Materials and completing Demolition, Flood Water Fire Damage Restoration from Government, Commercial, Industrial ...- Free Hockey Tickets Available At Mt Baldy Ski Lifts
For a limited time Mt Baldy Ski Lifts is offering free hockey tickets.
“It’s Ontario Reign Week at Mt Baldy. Anybody that buys a half price lift ticket and skis ...- Barbara Wirostko, Pfizer â€" to present at the 2nd Annual Ocular Disease Conference
Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will present on Endothelin: A Potential Novel Mechanism for Future Drug Development in Ophthalmology at GTCbio’s 2nd Annual Ocular Disease ...- Paget’s Disease - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData’s analysis reveals that the Paget’s disease market was worth $159.2m in 2009. It is forecast to exhibit a negative compound annual growth rate (CAGR) of 8.9% for the next ...- Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData estimated that the Lyme disease market was worth $2.2m in 2009. The major reason for the limited market revenues is that there is no approved drug for Lyme disease ...
|
|
|
